• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征女性的兄弟姐妹的心血管疾病风险。

Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome.

机构信息

Department of Endocrinology, Silverline Hospital, Kochi, India.

Department of Endocrinology, Aster Medcity, Kochi, India.

出版信息

Hum Reprod. 2019 Aug 1;34(8):1559-1566. doi: 10.1093/humrep/dez104.

DOI:10.1093/humrep/dez104
PMID:31299073
Abstract

STUDY QUESTION

Do the siblings of Asian Indian women with polycystic ovary syndrome (PCOS) manifest increased cardiovascular disease (CVD) risk by carotid intima-media thickness (CIMT) and brachial artery flow-mediated dilatation (FMD)?

SUMMARY ANSWER

Siblings had functional endothelial dysfunction (FMD was reduced) when compared to age and BMI-matched controls while sisters but not brothers had structural endothelial dysfunction (CIMT was increased).

WHAT IS KNOWN ALREADY

Siblings of women with PCOS have increased metabolic risk but it varies with ethnicity. Among Asian Indians the only previous study has shown reduced FMD in brothers.

STUDY DESIGN, SIZE, DURATION: This study was a tertiary care hospital-based cross-sectional case control study in the outpatient department of the endocrine clinic over 18 months. In total, 41 brothers and 35 sisters of women with PCOS (diagnosed by 2003 Rotterdam criteria) were recruited.

PARTICIPANTS/MATERIALS, SETTING, METHODS: Age (±2 years), sex and BMI- (±1 kg/m2) matched controls were selected. Cases and controls underwent clinical and biochemical investigations. Cardiologists performed doppler ultrasonogram to determine CIMT and FMD in a blinded fashion.

MAIN RESULTS AND THE ROLE OF CHANCE

FMD was decreased in brothers [median 12.3% interquartile range (5.1, 19) versus 18.4% (12.6, 21.5), P = 0.002] and in sisters [10.8% (5.8, 17.2) versus 14.7% (11.4, 18.2), P = 0.027] when compared to controls. CIMT was higher in sisters [median 0.4 mm (0.35, 0.5) versus 0.3 mm (0.3, 0.4), P= 0.002] when compared to controls but not in brothers. Metabolic syndrome was more common in brothers (27% versus 5% in controls, P = 0.007) even after matching for age and BMI. Insulin resistance (homeostatic model assessment for insulin resistance and acanthosis) was higher in brothers as compared to controls. Dehydroepiandrosterone sulphate was significantly elevated in brothers.

LIMITATIONS, REASONS FOR CAUTION: There may have been referral bias of patients with PCOS in a tertiary care institute, and the radiological assessment was performed by two cardiologists serially on different time frames over the study duration. Power was only 50% in CIMT for brothers.

WIDER IMPLICATIONS OF THE FINDINGS

Siblings of women with PCOS had higher CVD risk over and above the already pre-existing higher metabolic risk associated with Asian Indian ethnicity and therefore the siblings require vigilant management. Endothelial dysfunction and insulin resistance seems to be a heritable trait of PCOS independent of obesity, which if confirmed in other ethnicities would have important implications.

STUDY FUNDING/COMPETING INTEREST(S): Funded by Intramural Research Grant (PGI/DIR/RC/943/2013) from the Sanjay Gandhi Postgraduate Institute of Medical Sciences. No competing interests.

摘要

研究问题

多囊卵巢综合征(PCOS)女性的兄弟姐妹是否通过颈动脉内膜中层厚度(CIMT)和肱动脉血流介导的扩张(FMD)表现出心血管疾病(CVD)风险增加?

总结答案

与年龄和 BMI 匹配的对照组相比,兄弟姐妹存在功能性内皮功能障碍(FMD 降低),而仅姐妹存在结构性内皮功能障碍(CIMT 增加)。

已知情况

PCOS 女性的兄弟姐妹存在代谢风险增加,但存在种族差异。在亚洲印第安人中,唯一的先前研究表明兄弟的 FMD 降低。

研究设计、规模、持续时间:这是一项三级保健医院为基础的门诊内分泌诊所的横断面病例对照研究,持续了 18 个月。总共招募了 41 名 PCOS 女性的兄弟和 35 名姐妹(根据 2003 年鹿特丹标准诊断)。

参与者/材料、地点、方法:选择年龄(±2 岁)、性别和 BMI(±1kg/m2)匹配的对照组。病例和对照组接受了临床和生化检查。心脏病专家以盲法方式进行多普勒超声检查以确定 CIMT 和 FMD。

主要结果和机会的作用

与对照组相比,兄弟的 FMD 降低[中位数 12.3%(5.1,19)与 18.4%(12.6,21.5),P=0.002],姐妹的 FMD 也降低[中位数 10.8%(5.8,17.2)与 14.7%(11.4,18.2),P=0.027]。与对照组相比,姐妹的 CIMT 更高[中位数 0.4mm(0.35,0.5)与 0.3mm(0.3,0.4),P=0.002],但兄弟的 CIMT 没有增加。代谢综合征在兄弟中更为常见(27%与对照组的 5%,P=0.007),即使在年龄和 BMI 匹配后也是如此。与对照组相比,兄弟的胰岛素抵抗(稳态模型评估的胰岛素抵抗和棘皮症)更高。脱氢表雄酮硫酸盐在兄弟中显著升高。

局限性、谨慎的原因:在三级保健机构中,PCOS 患者可能存在转诊偏倚,并且在研究期间,放射学评估由两名心脏病专家在不同的时间框架上连续进行。在兄弟中,CIMT 的功率仅为 50%。

研究结果的更广泛影响

PCOS 女性的兄弟姐妹的 CVD 风险高于已经存在的与亚洲印第安人种族相关的更高的代谢风险,因此兄弟姐妹需要进行警惕性管理。内皮功能障碍和胰岛素抵抗似乎是 PCOS 的遗传特征,独立于肥胖,如果在其他种族中得到证实,将具有重要意义。

研究资助/利益冲突:由 Sanjay Gandhi 研究生医学科学研究所的内部研究拨款(PGI/DIR/RC/943/2013)资助。没有竞争利益。

相似文献

1
Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome.多囊卵巢综合征女性的兄弟姐妹的心血管疾病风险。
Hum Reprod. 2019 Aug 1;34(8):1559-1566. doi: 10.1093/humrep/dez104.
2
Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.年轻女性的中心动脉僵硬度和舒张功能障碍与胰岛素抵抗及腹型肥胖相关,但多囊卵巢综合征并不会增加额外风险。
Hum Reprod. 2014 Sep;29(9):2041-9. doi: 10.1093/humrep/deu180. Epub 2014 Jul 17.
3
Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome.多囊卵巢综合征女性一级亲属的心血管疾病风险
Fertil Steril. 2016 May;105(5):1338-1344.e3. doi: 10.1016/j.fertnstert.2016.01.024. Epub 2016 Feb 4.
4
Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.肥胖和非肥胖多囊卵巢综合征女性中肥胖抑制素和 copeptin 的循环水平。
Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:19-23. doi: 10.1016/j.ejogrb.2015.03.006. Epub 2015 Mar 9.
5
Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.多囊卵巢综合征女性患者的兄弟存在促性腺激素分泌及类固醇生成异常的证据。
Hum Reprod. 2014 Dec;29(12):2764-72. doi: 10.1093/humrep/deu282. Epub 2014 Oct 21.
6
Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.多囊卵巢综合征年轻印度女性的心血管疾病风险。
Gynecol Endocrinol. 2014 Jan;30(1):26-9. doi: 10.3109/09513590.2013.831835. Epub 2013 Sep 10.
7
Familial clustering of metabolic phenotype in brothers of women with polycystic ovary syndrome.多囊卵巢综合征女性兄弟的代谢表型家族聚集性。
Gynecol Endocrinol. 2019 Jul;35(7):601-603. doi: 10.1080/09513590.2019.1566451. Epub 2019 Feb 6.
8
Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.女性各种卵巢功能障碍患者的雄激素水平:与心脏代谢特征的关联。
Hum Reprod. 2015 Oct;30(10):2376-86. doi: 10.1093/humrep/dev195. Epub 2015 Aug 12.
9
Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.多囊卵巢综合征超重及肥胖女性的血流介导的血管舒张功能
BJOG. 2006 Nov;113(11):1308-14. doi: 10.1111/j.1471-0528.2006.01090.x.
10
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.多囊卵巢综合征女性在正常血糖高胰岛素钳夹试验中存在固有胰岛素抵抗。
Hum Reprod. 2013 Mar;28(3):777-84. doi: 10.1093/humrep/des463. Epub 2013 Jan 12.

引用本文的文献

1
Association of The rs1024611 Polymorphism with Polycystic Ovary Syndrome in A Population of Indian Women: A Case-Control Study.印度女性群体中rs1024611多态性与多囊卵巢综合征的关联:一项病例对照研究。
Int J Fertil Steril. 2025 Jan 5;19(1):44-49. doi: 10.22074/ijfs.2024.1974120.1406.
2
Polycystic ovary syndrome.多囊卵巢综合征。
Nat Rev Dis Primers. 2024 Apr 18;10(1):27. doi: 10.1038/s41572-024-00511-3.
3
SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
SPIOMET4HEALTH 研究方案:生活方式干预联合螺内酯、吡格列酮和二甲双胍固定剂量复方治疗青春期女孩和年轻女性多囊卵巢综合征的疗效、耐受性和安全性:一项多中心、随机、双盲、安慰剂对照、四臂、平行分组、二期临床试验
Trials. 2023 Sep 15;24(1):589. doi: 10.1186/s13063-023-07593-6.
4
Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome.多囊卵巢综合征雄性后代生殖和代谢功能障碍的跨代传递。
Cell Rep Med. 2023 May 16;4(5):101035. doi: 10.1016/j.xcrm.2023.101035. Epub 2023 May 5.
5
Update on Animal Models of Polycystic Ovary Syndrome.多囊卵巢综合征动物模型的研究进展。
Endocrinology. 2022 Oct 23;163(12). doi: 10.1210/endocr/bqac164.
6
Metabolic risk factors and fertility disorders: A narrative review of the female perspective.代谢风险因素与生育障碍:女性视角的叙述性综述
Reprod Biomed Soc Online. 2021 Oct 1;14:66-74. doi: 10.1016/j.rbms.2021.09.002. eCollection 2022 Mar.
7
Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia.瑞舒伐他汀治疗混合性血脂异常伴早发性雄激素性脱发男性的心血管代谢危险因素。
Molecules. 2021 May 11;26(10):2844. doi: 10.3390/molecules26102844.
8
Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.小檗碱通过抑制炎症反应和细胞凋亡对多囊卵巢综合征大鼠发挥保护作用。
Reprod Biol Endocrinol. 2021 Jan 7;19(1):3. doi: 10.1186/s12958-020-00684-y.
9
The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.阿托伐他汀对多囊卵巢综合征女性兄弟的心血代谢危险因素的影响。
Pharmacol Rep. 2021 Feb;73(1):261-268. doi: 10.1007/s43440-020-00135-w. Epub 2020 Jul 21.